Unknown

Dataset Information

0

Seatbelts in CAR therapy: How Safe Are CARS?


ABSTRACT: T-cells genetically redirected with a chimeric antigen receptor (CAR) to recognize tumor antigens and kill tumor cells have been infused in several phase 1 clinical trials with success. Due to safety concerns related to on-target/off-tumor effects or cytokine release syndrome, however, strategies to prevent or abate serious adverse events are required. Pharmacologic therapies; suicide genes; or novel strategies to limit the cytotoxic effect only to malignant cells are under active investigations. In this review, we summarize results and toxicities of investigations employing CAR redirected T-cells, with a focus on published strategies to grant safety of this promising cellular application.

SUBMITTER: Minagawa K 

PROVIDER: S-EPMC4491658 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Seatbelts in CAR therapy: How Safe Are CARS?

Minagawa Kentaro K   Zhou Xiaoou X   Mineishi Shin S   Di Stasi Antonio A  

Pharmaceuticals (Basel, Switzerland) 20150508 2


T-cells genetically redirected with a chimeric antigen receptor (CAR) to recognize tumor antigens and kill tumor cells have been infused in several phase 1 clinical trials with success. Due to safety concerns related to on-target/off-tumor effects or cytokine release syndrome, however, strategies to prevent or abate serious adverse events are required. Pharmacologic therapies; suicide genes; or novel strategies to limit the cytotoxic effect only to malignant cells are under active investigations  ...[more]

Similar Datasets

| S-EPMC7518381 | biostudies-literature
| S-EPMC6257951 | biostudies-literature
| S-EPMC8621371 | biostudies-literature
| S-EPMC9942695 | biostudies-literature
| S-EPMC5423782 | biostudies-literature
| S-EPMC4931286 | biostudies-literature
| S-EPMC8027274 | biostudies-literature
| S-EPMC4732525 | biostudies-other
| S-EPMC3827208 | biostudies-literature